Register and share your invite link to earn from video plays and referrals.

Search results for BOS
BOS community
One keyword maps to one global community path.
Create community
People
Not Found
Tweets including BOS
Boston Globe: Chris Sununu rules out US Senate bid in New Hampshire for 2028
Bose QuietComfort 2nd gen noise cancelling headphones are $219 on Amazon, down from $359 #ad#
Boston Symphony CEO Chad Smith said the orchestra, which recently parted ways with its brilliant and popular conductor Andris Nelsons, must serve communities “more expansively and inclusively” and think differently about “whose voices get to be heard, whose stories get to be told.” In her latest essay, @HMDatMI rejects that woke conceit with characteristic ferocity. “If a listener needs to see himself ‘reflected,’ it would be more efficient to take a selfie than to attend a performance of a Mozart piano concerto,” she writes. One listens to Mozart “to lose oneself in a bygone world of grandeur and beauty.” Down with phony inclusivity, she argues—and up with transcendent art.
Show more
Boston College pulls off insane 'Ring Around the Rosie' trick play for touchdown
Boss just insta killed 3/4 of your team and you hear-
0
12
3.1K
118
Forward to community
Boston Scientific Corporation 2026 Q3 - Results - Earnings Call Presentation $BSX #finance# #stockmarket# #economy#
Boston Scientific’s shares dropped after it lowered its sales outlook and said it expects fourth-quarter sales to decline
Boston Scientific Q3 2026 Earnings - Net Sales: $5.14B (est $5.05B) - Adjusted EPS: 73c (est 73c) - Sees FY Adjusted EPS: $3.16 To $3.18 (est $3.23)
BOSTON SCIENTIFIC $BSX Q3’26 EARNINGS HIGHLIGHTS 🔹 Net Sales: $5.1B (Est. $5.05B) 🟢 🔹 Adj. EPS: $0.73 (Est. $0.72) 🟢; -3% YoY 🔹 GAAP EPS: $0.40; -22% YoY FY26 Guide: 🔹 Adj. EPS: $3.16-$3.18 (Est. $3.23) 🔴 🔹 Reported Net Sales Growth: ~+4.25% 🔹 Organic Net Sales Growth: ~+3.75% Q4 Guide: 🔹 Adj. EPS: $0.77-$0.79 (Est. $0.84) 🔴 🔹 Reported Net Sales Growth: -3.0% to -1.0% 🔹 Organic Net Sales Growth: -3.0% to -1.0% Segment Net Revenue: 🔹 MedSurg: $1.7B; +0.6% YoY 🔹 Cardiovascular: $3.4B; +1.9% YoY 🔹 Endoscopy: $741M; -0.8% YoY 🔹 Urology: $661M; -3.2% YoY 🔹 Neuromodulation: $331M; +13.1% YoY Announcements: 🔹 StoneSmart Solutions: FDA 510(k) clearance for two technologies 🔹 SEISMIQ: FDA 510(k) clearance for expanded sizing 🔹 Renal Denervation: Category I CPT codes effective January 2028 Other Q3 Metrics: 🔹 Net Sales Growth: +1.5% reported; +1.5% organic Comments: 🔸 “particularly to the cybersecurity incident, working with urgency and resilience to restore operations and continue supporting customers and patients.” 🔸 “As we move forward, I remain confident in our long-term strategy, fueled by our dedicated talent, differentiated portfolio and strong pipeline of meaningful innovation.”
Show more
【Boss Blitz】 Complete missions, accumulate Stars, and climb the leaderboard! Based on your ranking, you can earn rewards including Stellanite Dust and Honor Titles. ▌Enemy Information Count of the Duloos – Enemy Vulnerability: Lux, Aqua Lithe Beauty – Enemy Vulnerability: Lux, Terra ▌Period Oct. 31, 2026 13:00 – Nov. 29, 2026 07:59 (UTC-7) #StellaSora# #Yostar# #StellaSora1stAnniv#
Show more